Stock ORPHA ORPHAZYME A/S
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Orphazyme A/S

Equities

ORPHA

DK0062502894

Delayed Nasdaq Copenhagen
Other stock markets
 03:21:24 2024-05-23 am EDT 		5-day change 1st Jan Change
1,020 DKK +0.06% Intraday chart for Orphazyme A/S -3.59% -23.32%
Mar. 27 Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 04 FDA Extends Review of Zevra's Arimoclomol by Three Months DJ

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ORPHAZYME A/S
Bio Therapeutic Drugs
+0.06%-3.59%-23.32%-46.27%-98.11% 5.23M
Neutral
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. ORPHA Stock
  4. Charts Orphazyme A/S
  5. Relative Strength Chart